While NRF2 is essential for protecting normal cells from genotoxic stress, its sustained activation in cancer provides a survival advantage to tumor cells, contributing to drug resistance, metastasis, and poor prognosis [75]. This evidence concerns the gene NFE2L2 and cancer.